BLASST-1 (Bladder Cancer Signal Seeking Trial): Nivolumab, Gemcitabine, and Cisplatin in Treatment of Muscle Invasive Bladder Cancer (MIBC) Undergoing Cystectomy
Clinical trial NCT03294304 · COMPLETED
Trial details
- NCT number
- NCT03294304
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-29
- Primary completion
- 2020-06-05
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.